A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Opko Health swings to Q1 net loss of US$55.4M from net income of US$31.1M a year ago, with consolidated revenue down at US$329.2M from US$545.2M a year ago; diagnostics revenue down at US$286.6M due to fewer COVID-19 tests, pharmaceuticals up at US$36.6M

FDA approves BLA 125521 for Eli Lilly’s Taltz injectable containing ixekizumab 80 mg/mL in one formulation to treat autoimmune disease; the drug is available by prescription only and has no therapeutic equivalents

AmerisourceBergen reports fiscal Q2 attributable net income up 25.9% from a year ago to US$548.0M, with revenue up 17.4% year-over-year to US$57.7B; US revenue up 5.8% year-over-year due to market growth, increased sales to specialty physician practices

Pfizer reports Q1 net profit up 61% from a year ago at US$7.9B, with revenue up 77% year-over-year at US$25.7B; growth driven by Comirnaty COVID-19 vaccine sales of US$13.2B, sales of Paxlovid nirmatrelvir and ritonavir COVID-19 treatment of US$1.5B

Biogen reports Q1 net profit down at US$303.8M from US$410.2M a year ago, with revenue down 6% year-over-year to US$2.5B; Q1 sees write-down of Alzheimer drug Aduhelm, drop in sales of Tecfidera, Spinraza due to generics, decline in Rituxan sales

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count